| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/02/2011 | EP2278966A2 Treatment with opioid antagonists and mtor inhibitors |
| 02/02/2011 | EP2089369B1 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 02/02/2011 | EP1606265B1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/02/2011 | EP1603949B9 Antibodies against human il-21 receptor and uses therefor |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN1683551B cow fetus agent prepared by composite enzyme method |
| 02/02/2011 | CN101965346A Novel pyrimidine-pyridine derivatives |
| 02/02/2011 | CN101965345A Pyridine compounds |
| 02/02/2011 | CN101962413A Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
| 02/02/2011 | CN101962402A Astragalus membranaceus glycoprotein as well as preparation method and usage thereof |
| 02/02/2011 | CN101962365A Aminoindazole derivatives as protein-kinase inhibitors |
| 02/02/2011 | CN101962349A 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof |
| 02/02/2011 | CN101961485A Selenium-enriched collagen and inulin composition with functions of enhancing immunity and reducing blood sugar |
| 02/02/2011 | CN101961482A Immunity enhancer for aquatic animals |
| 02/02/2011 | CN101961378A Formula of health-care product for resisting oxidation and enhancing immunity |
| 02/02/2011 | CN101961371A Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla |
| 02/02/2011 | CN101961363A Preparation method of active pseudo-ginseng slices |
| 02/02/2011 | CN101961362A Method for preparing active pseudo-ginseng granule |
| 02/02/2011 | CN101961361A Method for preparing active pseudo-ginseng |
| 02/02/2011 | CN101961349A Sea cucumber reinforced agglutinin and method thereof for preventing sea cucumber infective diseases |
| 02/02/2011 | CN101961343A Injection ribonucleic acid and production method thereof |
| 02/02/2011 | CN101961331A Ubiquitin E1 inhibitor and preparation method thereof |
| 02/02/2011 | CN101961330A Anti-stress agent for aquatic livestock |
| 02/02/2011 | CN101961104A Health care product or medicinal composition for strengthening bones and filling marrows and preparation method and application thereof |
| 02/02/2011 | CN101669899B Sustained-release implant taking maize protein as main framework material or matrix and use thereof |
| 02/02/2011 | CN101653413B Tacrolimus ophthalmic emulsion and its preparation method |
| 02/02/2011 | CN101596177B Coenzyme Q10 self-emulsifying composition, preparation method and application thereof |
| 02/02/2011 | CN101407558B Preparation of Dendrobium nobile polysaccharide extract and use there |
| 02/02/2011 | CN101278947B Yellow-back fungus fermentation product, composition containing the fermentation product and preparation method thereof |
| 02/02/2011 | CN101129354B Pharmaceutical composition containing triacetyl andrographolidume and medical use of the same |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879849 such as 1-(2-Methylpropyl)-2-propyl-2H-pyrazolo[3,4-c]quinolin-4-amine, used as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of viral and neoplastic diseases |
| 02/01/2011 | US7879844 Heterocyclic janus kinase 3 inhibitors |
| 02/01/2011 | US7879832 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879547 Method of detecting the presence of asthma or allergies in a patient |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 02/01/2011 | CA2536728C Method and composition for treating rhinitis |
| 02/01/2011 | CA2490896C Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2467097C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2404368C Pharmaceutical compositions |
| 02/01/2011 | CA2382887C Immunopotentiating compositions |
| 02/01/2011 | CA2380857C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/01/2011 | CA2342133C Ophthalmic formulations |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 02/01/2011 | CA2286385C Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 02/01/2011 | CA2282779C Formulation comprising an antigen, an adjuvant and an amino acid for use in immunization. |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 01/27/2011 | WO2011011753A1 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | WO2011011733A2 Factor replacement therapy |
| 01/27/2011 | WO2011010737A1 Guide nucleic acid for cleavage of micro-rna |
| 01/27/2011 | WO2011010732A1 Composition for external preparation for skin |
| 01/27/2011 | WO2011010583A1 Method for screening for oligonucleotide, and oligonucleotide library |
| 01/27/2011 | WO2011010090A1 Therapeutic uses for plants of the capsicum genus |
| 01/27/2011 | WO2011010080A1 Inhibitor of inflammatory conditions |
| 01/27/2011 | WO2010133475A3 Infant feeding formulas comprising probiotic micro-organisms |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021593 Novel crystal of substituted phenylalkanoic acid ester and process for producing the same |
| 01/27/2011 | US20110021590 Aminopyrrolidinone derivatives and uses thereof |
| 01/27/2011 | US20110021586 Phenyl-sulfamates as aromatase inhibitors |
| 01/27/2011 | US20110021582 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021553 Immunosuppressive macrolide powder for oral suspension |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021548 Inhibitors of malt1 proteolytic activity and uses thereof |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021523 Aryl sulfonamides |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021515 Dihyrofuropyrmindine compounds |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021494 Novel tetrahydro-fused pyridines as histone deacetylase inhibitors |
| 01/27/2011 | US20110021481 Novel Compounds and Methods for Their Production |
| 01/27/2011 | US20110021449 Macrolides and uses of macrolides |
| 01/27/2011 | US20110021443 OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
| 01/27/2011 | US20110021428 Prevention of allergy at weaning |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020870 Methods for producing modified glycoproteins |
| 01/27/2011 | US20110020464 Methods of treatment using thymus-derived compositions |
| 01/27/2011 | US20110020438 Crystallization Inhibitor and Its Use in Gelatin Capsules |
| 01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |
| 01/27/2011 | US20110020401 Tissue targeted antigenic activation of the immune response to treat cancers |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020398 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 01/27/2011 | US20110020395 Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings |
| 01/27/2011 | US20110020394 Pcv2 orf2 virus like particle with foreign amino acid insertion |
| 01/27/2011 | US20110020393 Method of Producing Japanese Encephalitis Vaccine Stably Storable Over Long Time and Use of the Vaccine |
| 01/27/2011 | US20110020390 Meningococcal fhbp polypeptides |